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underexpanding balloon-expandable transcatheter heart valves (THV) when excessive oversizing is a concern.Background Transcatheter aortic valve replacement depends on the selection of an optimally sized THV. An undersized THV may
lead to paravalvular regurgitation, whereas excessive oversizing may lead to annular injury.Methods Patients (n ¼ 47) who underwent transcatheter aortic valve replacement with an intentionally underexpanded THV
(balloon-ﬁlling volume reduced w10%) were compared with consecutive control patients who had nominal THV
balloon deployment (n ¼ 87). Pre- and post-procedural computed tomography imaging and echocardiography were
performed to assess THV stent expansion and hemodynamics.Results Underﬁlling resulted in THV underexpansion that was maximal at the THV inﬂow (85.0  7.4% vs. 102.5  6.2%,
p < 0.001), in study versus control groups, respectively. The study group received larger THV, although annular injury
was not observed. Post-dilation was required in 10.6% and 4.6% of patients of the study and control groups,
respectively (p ¼ 0.165). Echocardiographic THV area, gradient, paravalvular regurgitation, and in-hospital outcomes
were similar.Conclusions Intentionally underexpanding balloon-expandable THV by underﬁlling the deployment balloon did not adversely
affect procedural clinical outcomes, THV gradients, or THV areas. A strategy of underexpansion, with post-dilation as
necessary, might play in role in reducing the risk of annular injury and paravalvular regurgitation in selected
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Computed tomography (CT) imaging can help optimize
balloon-expandable THV size selection and reduce PVR
(1,3). However, balloon-expandable valves are currently
only available in a limited number of sizes. Patients with
“borderline” annular dimensions, where the annular dimen-
sions support transitioning from a smaller to a larger valve,
represent a particular challenge. For example, when tran-
sitioning from a 23-mm to a 26-mm THV, the implant
diameter increases by 3 mm or 13%, perimeter by 9.42 mm or
13%, and cross-sectional area by 1.15 cm2 or 28%.
Routine balloon-expandable deployment results in THV
inﬂow diameters slightly below the stated nominal THV
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977diameter (1,3). In vitro analysis shows that reducing balloon-
ﬁll volumes by w10% results in only minor hemodynamic
functional changes. We hypothesized that using a strategy
of underexpansion with ad hoc post-dilation as necessary
when selecting a THV that would result in annular area
oversizing>20% (or>10%with adverse root features) might
reduce the risk of annular injury without increasing the
rate of signiﬁcant PVR.THV = transcatheter heart
valveMethods
Forty-seven consecutive patients with severe aortic stenosis
who underwent TAVR with an intentionally underexpan-
ded Sapien type THV (Edwards Lifesciences Inc., Irvine,
California) at St. Paul’s Hospital, Vancouver, Canada,
and Aarhus University Hospital, Aarhus, Denmark, were
included in this prospective study. For comparison, a
historical cohort of 87 consecutive patients who had
undergone balloon-expandable TAVR with nominally ﬁlled
deployment balloons at St. Paul’s Hospital (control group)
was identiﬁed. All patients underwent pre- and post-
procedure CT and echocardiographic imaging (Online
Appendix).
The manufacturer’s recommended nominal ﬁlling
volume of the deployment balloons for the 20-, 23-, 26-,
and 29-mm Sapien XT were 11, 17, 22, and 33 ml
for the NovaFlex delivery system (Edwards Lifesciences)
and (no Ascendra 20-mm system is available), 16, 20,Figure 1 THV Balloon Volumes
Percentages of volume reduction across the different transcatheter heart valves (THV) anand 30 ml for the Ascendra
delivery system (Edwards Life-
sciences). Our strategy was to
underexpand THV when tran-
sitioning from a smaller to a lar-
ger implant by underﬁlling the
deployment balloonw10%. Con-
sequently, at the discretion of
the operator, 20-, 23-, 26-, and
29-mm balloons were underﬁlled
up to 1, 2, 3, and 4 ml, respectively (Fig. 1).
The study cohort then was divided in 3 subgroups
(Groups A, B, and C) according to the percentage of volume
reduction from the THV balloon (Fig. 1). Criteria for
intentional balloon underﬁlling were >20% area oversizing
as determined from pre-procedural CT or >10% area
oversizing with adverse root features (left ventricular out-
ﬂow tract calciﬁcation, shallow sinuses of Valsalva, extreme
age, previous chest irradiation, female sex, relatively small
body size).
Statistical analysis and deﬁnitions. Continuous variables
are reported as mean  SD and categorical variables as
percentages. Continuous variables were tested for a normal
distribution (QQ plot) and compared by the Student t test.
For comparison of >2 continuous parametric variables, an
analysis of variance was used. Categorical variables were
compared by the Fisher exact or chi-square tests. Bonferroni
adjustment was used when appropriate. All tests wered delivery systems according to the degree of underﬁlling. *Not recommended.
Table 1 Baseline Clinical, Echocardiographic, and CT Characteristics
Overall
(n ¼ 134)
Study Group
(n ¼ 47)
Control Group
(n ¼ 87) p Value
Clinical variables
Age, yrs 81.9  7.7 82.0  7.6 81.8  7.8 0.897
Female 55 (42.3) 25 (53.2) 33 (37.9) 0.089
Diabetes mellitus 41 (30.6) 18 (38.3) 23 (26.4) 0.155
Peripheral vascular disease 20 (14.9) 6 (12.8) 14 (16.1) 0.491
Porcelain aorta 14 (10.4) 3 (6.4) 11 (12.6) 0.290
GFR <60 ml/min 77 (57.5) 32 (68.1) 45 (51.7) 0.068
Pacemaker 17 (12.7) 6 (12.8) 11 (12.6) 0.984
STS score, % 6.5  3.9 5.4  2.6 7.0  4.3 0.025
Echocardiographic variables
Left ventricular ejection fraction, % 53.9  13.6 54.1  11.8 53.8  13.6 0.908
Mean aortic gradient, mm Hg 42.4  17.2 46.4  17.7 40.2  17.1 0.051
Aortic valve area, cm2 0.68  0.16 0.64  0.17 0.70  0.15 0.054
Aortic regurgitation moderate 12 (8.9) 5 (10.6) 7 (8.0) 0.549
CT variables
Annulus maximum diameter, mm 27.2  2.9 27.7  3.2 26.9  2.8 0.168
Annulus minimum diameter, mm 21.1  2.2 21.6  2.3 21.1  2.2 0.198
Annulus mean diameter, mm 24.1  2.6 24.3  3.2 24.0  2.2 0.495
Annulus area, cm2 4.8  0.9 4.9  0.9 4.8  0.9 0.458
Annulus eccentricity index 2.1  0.7 2.1  0.8 2.1  0.7 0.942
Values are mean  SD or n (%).
CT ¼ computed tomography; GFR ¼ glomerular ﬁltration rate; STS ¼ Society of Thoracic Surgeons.
Barbanti et al. JACC Vol. 63, No. 10, 2014
Underexpansion and Post-Dilation in Balloon-Expandable TAVR March 18, 2014:976–81
9782-tailed and a p value of <0.05 was considered signiﬁcant.
Analyses were performed using SPSS statistics software
(SPSS Inc., Chicago, Illinois). Outcomes are reported
according to Valve Academic Research Consoritum-2
criteria (4).
Results
Clinical, echocardiographic, and CT characteristics are
summarized in Table 1. Pre-operative variables were similar,Table 2 Procedural Variables
Overall (n ¼ 134) Study G
Access
Transfemoral 122 (91.0) 4
Transapical 12 (9.0)
Prosthesis type
Sapien XT 128 (97.8) 4
Sapien 3 3 (2.2)
Prosthesis size, mm
20 1 (0.7)
23 40 (29.9)
26 68 (50.7) 2
29 25 (18.7) 1
Post-dilation 9 (6.7)
Valve embolization 0 (0.0)
Valve-in-valve 0 (0.0)
Annular rupture 0 (0.0)
PVR more than mild 7 (5.2)
Transvalvular regurgitation 0 (0.0)
Values are n (%). Dashes indicate that p values were not applicable.
PVR ¼ paravalvular regurgitation.although patients in the study group had a lower Society
of Thoracic Surgeons) score (5.4  2.6% vs. 7.0  4.3%,
p ¼ 0.025). Aortic annulus CT measurements did not differ.
Procedural and echo outcomes. Procedural variables are
listed in Table 2. In the study group, the THV balloon was
underﬁlled by 1, 2, 3, and 4 ml in 8 (17.0%), 26 (55.3%), 11
(23.4%), and 2 (4.3%) patients, respectively. A strategy of
intentional underﬁlling was adopted due to >20% area
oversizing in 16 patients (34.0%) and due to >10% over-
sizing in association with adverse aortic root features inroup (n ¼ 47) Control Group (n ¼ 87) p Value
3 (91.4) 79 (90.8) 0.633
4 (8.5) 8 (9.2)
1 (93.6) 87 (100) 0.041
3 (6.4) 0 (0.0)
1 (2.1) 0 (0.0) 0.351
7 (14.9) 33 (37.9) 0.005
1 (44.7) 47 (54.0) 0.302
8 (38.3) 7 (8.0) <0.001
5 (10.6) 4 (4.6) 0.165
0 (0.0) 0 (0.0) d
0 (0.0) 0 (0.0) d
0 (0.0) 0 (0.0) d
1 (2.1) 6 (6.9) 0.225
0 (0.0) 0 (0.0) d
Table 3 Clinical In-Hospital Outcomes
Overall (n ¼ 134) Study Group (n ¼ 47) Control Group (n ¼ 87) p Value
Death 0 (0.0) 0 (0.0) 0 (0.0) d
Cerebrovascular events 0.420
Major stroke 0 (0.0) 0 (0.0) 0 (0.0)
Minor stroke 2 (1.5) 0 (0.0) 2 (2.3)
TIA 0 (0.0) 0 (0.0) 0 (0.0)
Major complications 0.760
Bleeding 1 (0.7) 0 (0.0) 1 (1.1)
Vascular 3 (2.2) 1 (2.1) 2 (2.3)
Pacemaker implantation 6 (4.5) 2 (4.3) 4 (4.6) 0.648
Values are n (%). Dash indicates that the p value was not applicable.
TIA ¼ transient ischemic attack.
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97931 patients (66.0%); 28 patients had extensive left ventric-
ular outﬂow tract calciﬁcation; 7 had shallow sinuses of
Valsalva; 4 had both; and 3 had small body size in relation to
the nominal stent cross sectional area. The study group
received larger THV; fewer 23-mm THV (14.9% vs. 24.6%,
p ¼ 0.005) and more 29-mm THV (38.3% vs. 8.0%,
p < 0.001). THV embolization, multiple valve implantation,
and annular injury did not occur.
Post-dilation was performed in 10.6% and 4.6% of
patients of the study and control groups, respectively
(p ¼ 0.165). Among the study group, post-dilation was
performed with nominal ﬁlling of the original balloon in 3
cases (in all these cases, the predicted area oversizing
was w10%). In the remaining 2 cases, the Sapien XT
29-mm THV balloon was underﬁlled by 4 ml and 3 ml,
respectively, and subsequently post-dilated underﬁlled byFigure 2 THV Frame Expansion
The ratio of actual transcatheter heart valve (THV) stent area measured with computed to
study group according to the percentage of volume reduction. UF ¼ underﬁlling.2 ml, in both cases, in the presence of a tubular aortic root
and predicted area oversizing >20% and severe annular
calciﬁcation, respectively. In all cases, moderate paravalvular
leaks were reduced to mild.
Echocardiographic THV area was 1.61  0.37 cm2
versus 1.66  0.41 cm2 (p ¼ 0.463) and mean THV
gradient was 11.4  4 mm Hg versus 10.6  3.9 mm Hg
(p ¼ 0.261) in the study and control groups, respectively.
PVR was more than mild in 1 patient (2.1%) in the study
group and 6 patients (6.9%) in the control group (p ¼
0.225). In-hospital complication rates are reported in
Table 3.
CT outcomes. THV expansion at the inﬂow was 85.0
 7.4% versus 102.5  6.2% (p < 0.001), at the mid-
portion, 88.0  7.0% versus 102.4  6.3% (p < 0.001),
and at the outﬂow, 91.5  6.9% versus 102.8  6.0%mography to nominal THV area according to THV size in the control group and in the
Table 4 Ratio of Actual THV Stent Area Measured With CT to Nominal THV Area According to THV Size and Degree of Underﬁlling
Not Underﬁlled 1 ml Underﬁlled 2 ml Underﬁlled 3 ml Underﬁlled 4 ml Underﬁlled p Value
Outﬂow portion
20-mm THV, n ¼ 1 N/A 99 (1) N/A N/A N/A N/A
23-mm THV, n ¼ 40 104  7 (33) 95  6 (4) 87  8 (3) N/A N/A <0.001
26-mm THV, n ¼ 68 103  5 (47) 96  9 (2) 92  5 (16) 96  9 (3) N/A <0.001
29-mm THV, n ¼ 25 98  4 (7) 91 (1) 87  6 (7) 90  8 (7) 87  1 (2) 0.101
Mid-portion
20-mm THV, n ¼ 1 N/A 91 (1) N/A N/A N/A N/A
23-mm THV, n ¼ 40 104  8 (33) 95  5 (4) 83  5 (3) N/A N/A <0.001
26-mm THV, n ¼ 68 102  5 (47) 99  7 (2) 87  6 (16) 83  5 (3) N/A <0.001
29-mm THV, n ¼ 25 98  2 (7) 83 (1) 87  9 (7) 89  4 (7) 84  2 (2) 0.012
Inﬂow portion
20-mm THV, n ¼ 1 N/A 86 (1) N/A N/A N/A N/A
23-mm THV, n ¼ 40 104  8 (33) 90  4 (4) 81  5 (3) N/A N/A <0.001
26-mm THV, n ¼ 68 102  5 (47) 98  15 (2) 84  7 (16) 82  4 (3) N/A <0.001
29-mm THV, n ¼ 25 100  2 (7) 77 (1) 86  7 (7) 85  7 (7) 83  1 (2) <0.001
Values are mean  SD (n) or % (n).
CT ¼ computed tomography; N/A ¼ not applicable; THV ¼ transcatheter heart valves.
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980(p < 0.001) in study versus control groups, respectively
(Fig. 2, Table 4). THV eccentricity at the inﬂow was 3.6
 3.5 versus 2.5  2.4 (p ¼ 0.039), at the mid-portion, 4.0
 4.2 versus 2.7  2.7 (p ¼ 0.027), and at the outﬂow,
2.8  3.5 versus 2.7  2.7 (p ¼ 0.759) in study versus
control groups, respectively. An underexpansion strategy
was associated with a lower frequency of excess oversizing
(Figs. 3 and 4).
Discussion
In the context of TAVR, aortic annular dimensions are
established on the basis of noninvasive imaging. Modest CT
annular area oversizing facilitates minimal PVR with a lowFigure 3 Predicted and Actual Annular Area Oversizing
Rate of predicted computed tomography–based >20% annular area oversizing and
actual oversizing >20% in patients with normal and underﬁlled transcatheter heart
valve balloons.risk of annular injury (1,3). However, prosthesis area over-
sizing >20% is associated with a higher risk of aortic root
rupture; a risk that may be ampliﬁed by various factors,
particularly subannular calciﬁcation (2).
THV function. Echocardiographic transvalvular gradients,
effective oriﬁce areas, the absence of valvular regurgitation,
and procedural success were comparable in both groups.
Post-dilation due to PVR was more frequent in the under-
ﬁlled group than in the control group. PVR that was more
than mild was less frequent in the study group, although
this was not statistically signiﬁcant. Importantly, an over-
sized, but underexpanded, THV may allow for greater
ﬂexibility in terms of post-dilation than an undersized but
fully expanded THV would.Figure 4 Predicted Reduction in Area Oversizing
Actual annular area oversizing with balloon underﬁlling (UF) as compared to
predicted with nominal balloon ﬁlling.
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981Post-TAVR CT analysis. Nominally ﬁlled deployment
balloons resulted in a prosthesis cross-sectional CT area that
correlated well with the nominal THV area indicated by the
manufacturer. Underﬁlling by 3% to 6% resulted in a 15.4%
reduction in actual THV area; underﬁlling by 9% to 10%
resulted in an 18.4% reduction; and underﬁlling by 11% to
15% resulted in a 20% reduction. Underﬁlling resulted in
underexpansion that was most marked in the inﬂow
segment, likely due to the constraint of the annulus.
Study limitations. In vitro studies have demonstrated that
marked underexpansion of valve stent frames can result in
frame eccentricity, suboptimal leaﬂet coaptation, and contact
between the leaﬂets and the frame, potentially reducing
leaﬂet durability. Consequently, routine underexpansion
cannot be advocated in patients for whom speciﬁc concerns
do not exist and long-term durability is important. Among
the study group, we included 3 patients who received an
underexpanded Sapien 3 THV.
Conclusions
Intentionally underexpanding balloon-expandable THV by
modestly underﬁlling the deployment balloon led to
predictable reduction of THV expansion. This did not
adversely affect short-term clinical or echocardiographic
outcomes. A strategy of underexpansion with post-dilation
as necessary may offer the opportunity for a more individ-
ualized approach to TAVR allowing for the reduction of the
risk of both annular injury and paravalvular regurgitation in
patients with borderline annular geometry. The impact ofunderexpansion on durability and late outcomes remains to
be determined.
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APPENDIX
For supplemental computed tomography and echocardiographic methods,
please see the online version of this article.
